Prof. Dr. Jörg E. Drewes is a Full Professor and Chair at the Research Institute for Urban Water Management, Technical University of Munich (TUM), Germany. He also serves as Academic Program Director for Environmental Engineering at TUM and is a co-founder of Waterloop Solutions GmbH. His work spans advanced water treatment technologies, wastewater reuse, and environmental health surveillance. Affiliations : TUM, Colorado School of Mines, King Abdullah University of Science and Technology, UNSW Water Research Centre Research focuses on advanced oxidation processes , membrane fouling mitigation , micropollutant removal , and wastewater epidemiology for public health. His team develops integrated systems for water-energy-food nexus applications and graphene oxide-based treatment solutions. Recent publications address PFAS remediation , UVC-LED pre-treatment for biofouling control, and GIS-based wastewater surveillance models . Awards include the Bayerische Staatsmedaille (2023) and William Dunbar Medal (2022). 2023 : Bayerische Staatsmedaille 2022 : William Dunbar Medal 2018 : IWA Fellow He leads the Nexus@TUM initiative and contributes to EU water resilience strategies. Collaborations include projects in Germany, China, India, and Spain, focusing on climate-resilient water systems and resource recovery .
Prof. Dr. Mathias Christmann is a faculty member at the Institute of Chemistry and Biochemistry, Freie Universität Berlin , leading the research group in Organic Chemistry . His work focuses on strategic and methodological challenges in synthetic chemistry, particularly in total synthesis, organocatalysis, and renewable resource transformations. Position: Professor Contact: mathias.christmann@fu-berlin.de Location: Takustr. 3, Room 24.16, 14195 Berlin Research Interests include: Natural product-inspired small molecule synthesis for biological pathway modulation Minimizing C-C bond formations through selective functionalization of terpene building blocks Organocatalytic and metal-catalyzed reactions in multistep sequences Flow chemistry applications for scalable and sustainable synthesis Biological evaluation of TRPC channel agonists/antagonists for cancer therapy Publication Trends highlight expertise in total synthesis of complex terpenoids, organocatalysis for stereocontrolled reactions, flow chemistry for late-stage transformations, and TRPC4/5 channel modulation in renal cancer studies. His group pioneers asymmetric desymmetrization , photo-oxidation protocols , and electrosynthesis methods with minimal reagent waste. Advisees include PhD candidates Jan-Hendrik Dickoff , Mayar Elbendary , Nadine Kreidt , Tobias Olbrisch , Kamar Shakeri , and Zhen Wang , focusing on terpene-based drug discovery and catalytic reaction design.
Prof. Dr. Deniz Tasdemir is a Full Professor (W3) of Marine Natural Products Chemistry at GEOMAR Helmholtz-Zentrum für Ozeanforschung Kiel and serves as Director of the GEOMAR-Biotech center and Head of the Marine Natural Product Chemistry Research Unit. Her career spans institutions including the National University of Ireland Galway and UCL School of Pharmacy. PhD in Pharmacy, ETH Zurich (1997) Post-doctoral work, University of Utah (2001) Dr. Helmut Legerlotz Fellowship, University of Zurich (2002-2025) Her research focuses on marine chemical ecology , metabolomics , and bioprospecting for bioactive compounds from sponges, algae, and marine microbiomes. Recent work explores seagrass pathogen reduction, microbiome interactions, and aquafeed applications. Scientific awards include: Waters Award for Natural Products Innovation (2016) Egon Stahl Silver Medal (2005) Pierre Fabre Prize (2004) ETH Zurich Medal (1997) She leads collaborative projects on ocean sustainability and marine drug discovery, with editorial roles in Marine Drugs , Planta Medica , and Phytochemistry Letters .
Michael Groll serves as Professor and Chair of Biochemistry at the Technical University of Munich (TUM), where he leads structural biology and enzymology research with a focus on proteasome mechanisms and inhibitor development. His laboratory, located at the Ernst-Otto-Fischer-Str. 8 campus in Garching, maintains active collaborations in drug discovery for cancer and infectious diseases. His primary research domains include proteasome inhibition, enzyme catalysis, and natural product biosynthesis, employing X-ray crystallography, biochemical assays, and bioengineering to dissect molecular mechanisms. Recent work emphasizes AI-guided enzyme optimization, bacterial stress response targeting, and structural characterization of halogenation enzymes, reflecting interdisciplinary approaches bridging chemistry and biology. Analysis of his 2023-2025 publications reveals consistent innovation in proteasome-targeted therapeutics, with 15 high-impact papers featuring structural insights into enzyme-inhibitor complexes and biosynthetic pathways. Key trends include engineering megasynthetases for immunoproteasome inhibitors, optical control of protein degradation, and elucidating metal-dependent mechanisms in antibiotic biosynthesis. No scientific awards were documented in the provided source material. While specific grant details and student mentorship records were not disclosed, his extensive publication record indicates leadership in collaborative research projects involving structural biology and chemical biology methodologies. The Chair of Biochemistry under Prof. Groll operates as a hub for structural enzymology, housing facilities for protein crystallography, enzyme kinetics, and natural product characterization. His team actively contributes to TUM's research ecosystem through partnerships with pharmaceutical groups and international structural biology consortia.
University Medical Center Hamburg-EppendorfGermany
Stefan Kluge is a Professor at the Department of Intensive Care within the University Medical Center Hamburg-Eppendorf . With over 150 publications in 2025-2024 alone, his work focuses on critical care medicine, sepsis, ARDS, and cardiogenic shock. His recent research explores ARDS impact on liver cirrhosis outcomes Hyperoxia effects in traumatic brain injury Biomarkers for cardiogenic shock prognosis Novel retrograde limb perfusion techniques during ECPR Dual-energy CT for body composition analysis He contributes extensively to German national guidelines for nosocomial pneumonia and participates in multi-center critical care trials. Stefan Kluge's collaborations span neuro-intensive care , cardiovascular research , and infection/immunity domains. His work integrates machine learning applications and medical informatics to improve ICU decision-making.
Cornelia Betsch serves as Director of the Institute for Planetary Health Behaviour (IPB) at the University of Erfurt, where she holds a professorship in Health Communication within the Faculty of Philosophy. She is responsible for the Master's program in Health Communication through the Department of Media and Communication Studies and leads the Health Communication Working Group at the Bernhard Nocht Institute for Tropical Medicine in Hamburg as an external position. Her interdisciplinary work bridges behavioral science, psychology, and public health to address critical global challenges. Habilitation (2006), University of Erfurt: 'The role of risk perception and risk communication in prevention decisions – the example of vaccination decisions' PhD (Dr. phil., summa cum laude, 2006), University of Heidelberg: 'Preference for intuition and deliberation– measurement and consequences of affect- and cognition based decision making' Diplom in Psychology (2002), University of Heidelberg Betsch's research focuses on understanding health and planetary health behaviors, particularly examining vaccination behavior, prudent antibiotic use, and climate-friendly actions. Her work extends globally, with investigations in various African countries on vaccination and antibiotic practices. She pioneered the influential COVID-19 Snapshot Monitoring (COSMO) and subsequently developed the Planetary Health Action Survey (PACE), large-scale studies that regularly track public knowledge, risk perception, protective behaviors, and trust during crises. Her research emphasizes applying behavioral and cultural insights to design effective policy frameworks and explanatory communication that promotes positive health behaviors. The 15 most recent articles showcase Betsch's research evolution toward integrating behavioral science with planetary health, climate action, and vaccine communication. Her work increasingly examines the psychological foundations of climate behavior while maintaining her established expertise in vaccine hesitancy and antimicrobial resistance. Recent publications demonstrate methodological diversity, including systematic reviews, meta-analyses, survey experiments, and large-scale monitoring datasets that bridge academic research with practical policy applications. German Psychology Prize (2021) Thuringian Research Prize (2022) Betsch has secured research funding from independent research organizations, ministries, and foundations to support her work on health communication and planetary health behavior. She serves as a scientific advisor to multiple organizations including the WHO Technical Advisory Group on Behavioral and Cultural Insights, Science Media Center Germany, and Museum für Naturkunde Berlin. At the Bernhard Nocht Institute for Tropical Medicine, she established the WHO Collaborating Center for Behavioral Research in Global Health, demonstrating her commitment to translating research into global health practice. Her engagement extends to policy advising, having served on the Corona Expert Council of the Federal Chancellery during the pandemic. As Director of the Institute for Planetary Health Behaviour, Betsch leads an interdisciplinary team applying social and behavioral science perspectives to planetary health and the climate crisis. The institute serves as a hub for research, education, and science communication at the intersection of human health and environmental sustainability. Her work through the IPB emphasizes Open Science principles and aims to understand the comprehensive factors influencing climate-friendly behavior to identify effective intervention points for policy development.
Prof. Dr. Marc Schneider holds a professorship in Biopharmaceutics and Pharmaceutical Technology at Saarland University's College of Pharmacy . His research focuses on colloidal drug delivery systems, particularly nanostructured and non-spherical particle engineering for overcoming biological barriers in pulmonary and transdermal applications. He leads an internationally recognized lab in Saarbrücken, collaborating with Helmholtz Institute for Pharmaceutical Research Saarland (HIPS) and trinational institutions. Research Highlights: Development of inhalable nano/microparticle systems Surface modification of gelatin nanoparticles Characterization of mucus-penetrating particles 3D printing for microneedle fabrication Atomic Force Microscopy (AFM) for nanoparticle analysis Selected Scientific Awards: European Journal of Pharmaceutics and Biopharmaceutics Best Paper Award (2018) for mucus-penetrating nanoparticles Recognized in 'Ausgezeichnete Orte im Land der Ideen' competition (2018) for 'Nano-Mais' drug delivery system Collaborative Networks: Co-editor for Advanced Drug Delivery Reviews special issue on biological barriers Key participant in trinational Master's program in Biomedicine with Strasbourg, Mainz, and Luxembourg Active in Controlled Release Society (CRS) conferences and local chapters
Martin Kaltenpoth serves as Director at the Max Planck Institute for Chemical Ecology in Jena since 2020 and Professor for Evolutionary Ecology at Johannes Gutenberg University of Mainz since 2015. Previously, he led the Research Group Insect Symbiosis at the MPI for Chemical Ecology from 2009 to 2015. Education: PhD in Biology (summa cum laude), University of Würzburg, 2006 Diploma in Biology (with honors), University of Würzburg, 2003 His research centers on insect-bacterial symbioses , investigating evolutionary, ecological, and chemical dimensions of host-microbe interactions. Key foci include nutritional and defensive symbiosis in beetles, genomic adaptations of symbiotic bacteria, and chemical mediation of symbiotic relationships. His work bridges entomology, microbiology, and chemical ecology to unravel coevolutionary mechanisms. Analysis of recent publications reveals dominant trends in beetle-microbe systems, emphasizing symbiont roles in cuticle synthesis, antifungal defense, and host-plant adaptation. His studies frequently employ genomic, biochemical, and experimental approaches across diverse insect lineages. No scientific awards were documented in the source material. While specific advisees and grants remain unlisted, his leadership of research groups and dual academic appointments indicate active supervision of graduate researchers and externally funded projects in symbiosis evolution. Currently directing research at the Max Planck Institute, Kaltenpoth advances understanding of symbiotic systems with implications for evolutionary theory and sustainable pest management strategies.
Hartmut Michel is a Scientific Member and Director at the Max Planck Institute of Biophysics in Frankfurt, Germany, where he leads the Department of Molecular Membrane Biology. He has held this position since 1987 and has also served as an Adjunct Professor at the University of Frankfurt since 1989. Michel received his PhD in Biochemistry from the University of Wuerzburg in 1977 and completed postdoctoral work there before joining the Max Planck Institute of Biochemistry as a research associate. Michel's research focuses on membrane proteins, particularly in the areas of structural biology, biochemistry, photosynthesis, and respiratory complexes. His work has centered on understanding the structure and function of membrane proteins, especially cytochrome c oxidase and photosynthetic reaction centers. He pioneered techniques for membrane protein crystallization and has made significant contributions to understanding electron transfer processes and proton pumping mechanisms in respiratory enzymes. His publication record spans over four decades, with recent work focusing on cryo-EM structural analysis of membrane proteins including cytochrome bd oxidases, ABC transporters, and photosynthetic complexes. The research demonstrates a consistent trajectory from fundamental structural studies toward understanding functional mechanisms and applications in areas like antibiotic development and bioenergetics. Scientific Awards 1986 Leibniz Prize of the German Research Foundation 1988 Otto Bayer Prize (with Johann Deisenhofer) 1988 Nobel Prize in Chemistry (with Johann Deisenhofer and Robert Huber) 2008 Keilin Medal of the British Biochemical Society Honorary doctorates from the Universities of Wuerzburg and Bologna Michel has maintained an active research program with numerous collaborations across Europe and internationally. His laboratory has developed innovative approaches for membrane protein expression, purification, and structural characterization. The team has made significant contributions to understanding the structure-function relationships in respiratory chain components and photosynthetic apparatus. His department at the Max Planck Institute serves as a leading center for membrane protein research, with specialized facilities for protein crystallization, cryo-electron microscopy, and functional characterization of membrane proteins. The research has implications for understanding fundamental biological energy conversion processes and developing new therapeutic approaches targeting membrane proteins.
Professor Stephan A. Sieber is a leading researcher in bioorganic chemistry at the Technical University of Munich (TUM), where he holds the Chair of Organic Chemistry II within the TUM School of Natural Sciences. His research program focuses on developing new drugs against multidrug-resistant bacteria through a multi-disciplinary approach that integrates synthetic chemistry, functional proteomics, microbiology, and protein biochemistry. His laboratory has made significant contributions to identifying unprecedented antibacterial targets beyond the scope of current antibiotics and exploiting these for chemical manipulation. Recent work has increasingly incorporated machine learning approaches to accelerate antibiotic discovery, with notable publications on AI-guided pipelines, drug-target interaction prediction, and high-throughput screening optimization. Sieber's research has resulted in the discovery of new active substances, some of which are currently being optimized for medical applications. His group's publications reveal a strong focus on chemical proteome mining, natural product mode of action studies, and novel antibacterial target identification. The lab has published extensively in top journals including Nature Chemistry, Nature Communications, and ACS Central Science. Inhoffen Medal (2024) Max Bergmann Medal (2023) ERC Advanced Grant (2023) Merck Future Insight Prize (2020) Klaus Grohe Prize (2020) ERC Consolidator Grant (2016) Professor Sieber leads an active research group that maintains a strong presence in the scientific community through regular publications, conference presentations, and collaborations. His laboratory website and BlueSky presence (@sieberlab.bsky.social) demonstrate ongoing research activities and engagement with the broader scientific community. He has successfully secured significant research funding including multiple ERC grants that have supported his innovative work in antibiotic discovery.
Professor Charlotte Kloft is Head of the Department of Clinical Pharmacy & Biochemistry at the Institute of Pharmacy, Free University of Berlin since 2011, and spokesperson for the interdisciplinary Graduate Research Training Program PharMetrX 'Pharmacometrics and Computational Disease Modelling' since 2008. She previously served as Professor and Head of the Department of Clinical Pharmacy at Martin-Luther-University Halle-Wittenberg (2005-2011) and as Scientific Assistant/Senior Assistant at Freie Universität Berlin (1999-2005). Her academic credentials include a habilitation in Clinical Pharmacy from Freie Universität Berlin (2003) and a Dr. rer. nat. (summa cum laude) from the same institution (1997). She earned her license as a pharmacist in 1992 after completing pharmacy studies at Johannes Gutenberg-University, Mainz (1987-1991). Professor Kloft's research focuses on pharmacometrics, computational disease modeling, and therapeutic drug monitoring across multiple therapeutic areas. Her work bridges pharmaceutical sciences with clinical practice, with particular emphasis on personalized dosing strategies for oncology, antimicrobial resistance, and inflammatory bowel diseases. She has pioneered research in optimizing drug dosing through pharmacokinetic/pharmacodynamic modeling, with applications in both antibiotic and cancer therapies. Her recent publications demonstrate a strong evolution toward integrating advanced computational approaches with clinical pharmacology, including machine learning applications in pharmacometrics, personalized dosing strategies for biologics during pregnancy, and developing nationwide infrastructure for therapeutic drug monitoring in cancer therapy through the ON-TARGET study. Academic Center of Excellence of Pharsight (now Certara), USA (since 2000) Habilitationsreisestipendium of Dr. August and Dr. Anni Lesmüller-Stiftung (2002) Ernst-Reuter-Preis of Ernst-Reuter-Gesellschaft (1998) Joachim-Tiburtius-Preis of Berlin Senate (1998) Young Investigator Award of EORTC-PAMM (1997) Professor Kloft has successfully supervised numerous doctoral students whose research spans diverse areas including CAR-T cell therapy, antimicrobial resistance, inflammatory bowel disease treatment optimization, and pharmacokinetic modeling of novel therapeutic agents. Her research group has secured significant funding for projects including GlobalResist, ON-TARGET, ABIMMUNE, COMBINATORIALS, and TAIN. She leads a vibrant research ecosystem at the Free University of Berlin with strong collaborations across Europe and internationally, maintaining state-of-the-art laboratory facilities including Biosafety Level 2 certified labs for infectious disease research.
Thomas Alter is a Professor and Managing Director of the Institute of Food Safety and Food Hygiene at the School of Veterinary Medicine, Freie Universität Berlin, and serves as a member of the FAO Reference Center for Antimicrobial Resistance (FAO RC AMR). His leadership spans institutional administration and global antimicrobial resistance initiatives. His research centers on antimicrobial resistance mechanisms, food safety protocols, and veterinary public health systems, with emphasis on interdisciplinary approaches to combat antibiotic resistance in food production chains. These efforts directly support the mission of the Veterinary Centre for Resistance Research (TZR), where his work bridges veterinary medicine and human health security. The institute operates under the newly established Veterinary Centre for Resistance Research (TZR), which held its ceremonial opening on April 26, 2022. This center coordinates proteomics research, resistance monitoring, and international policy development through its specialized laboratories and collaborative networks.
Prof. Dr. Ulrich Kleinekathöfer is a Full Professor of Theoretical Physics at Constructor University (formerly Jacobs University Bremen) in the School of Science. His research focuses on computational physics and biophysics, particularly on light-harvesting complexes, membrane transport, and quantum dynamics in biological systems. He leads the Computational Physics and Biophysics research group and coordinates the MSCA Doctoral Training Network "PhotoCaM". His educational background includes: PhD from Max-Planck-Institut für Strömungsforschung, Göttingen (1996) Diploma in Physics from Universität Göttingen (1993) Habilitation in Physics from Technische Universität Chemnitz (2002) Prof. Kleinekathöfer's research spans multiple areas of computational biophysics and theoretical physics. His primary interests include excitation energy transfer in light-harvesting complexes , molecular transport through membrane channels and nanopores , and quantum dynamics in open systems . His group develops and applies advanced computational methods including molecular dynamics simulations, quantum chemistry calculations, and machine learning approaches to study these phenomena. A significant portion of his work focuses on photosynthetic systems, particularly how energy is transferred and converted in natural light-harvesting complexes, with implications for renewable energy technologies. His recent publications demonstrate a strong trend toward integrating machine learning with traditional computational methods, particularly in the fields of quantum chemistry and molecular dynamics. There's a clear focus on multifidelity approaches that balance computational efficiency with accuracy. His work spans from fundamental quantum dynamics to applied research on antibiotic transport mechanisms, showing remarkable breadth while maintaining depth in computational methodology development. His notable recognition includes: Tan Chin Tuan Exchange Fellowship, NTU Singapore (2019) Prof. Kleinekathöfer has supervised numerous PhD students and postdoctoral researchers, with a current group comprising several PhD candidates and research associates. His research is supported by multiple funding sources including the Deutsche Forschungsgemeinschaft (DFG), European Union through MSCA Doctoral Network PhotoCaM, and previously through the Innovative Medicines Initiative "Translocation" and Marie Curie Training Program "Translocation". His collaborative network spans internationally, with partnerships at institutions in Germany, USA, Greece, and Switzerland. The Computational Physics and Biophysics Group operates within Constructor University's research infrastructure, utilizing high-performance computing resources for their simulations. The group maintains active collaborations with experimental groups to validate and inform their computational models, creating a strong interdisciplinary research environment focused on understanding fundamental biophysical processes at the molecular level.
Univ.-Prof. Dr. med. Martin A. Kriegel serves as full Professor and Department Head of the Department of Translational Rheumatology and Immunology at the Institute of Musculoskeletal Medicine, University of Münster, while maintaining an active laboratory at Yale School of Medicine. He leads the Section for Rheumatology and Clinical Immunology (SRKI) at Medical Clinic D, where his team integrates clinical care with cutting-edge microbiome research. His department operates from Röntgenstraße 21 and Von-Esmarch-Str. 54 in Münster, Germany, with extensive collaborations including the "Cells in Motion" research initiative and the CiM-IMPRS graduate program. Dr. Kriegel's research program focuses on the critical interface between host immunity and microbiota, particularly investigating how gut commensals translocate to host tissues and trigger autoimmune responses. His laboratory pioneered the discovery that specific pathobionts like Enterococcus gallinarum and certain Lactobacillus strains can translocate from the gut to mesenteric lymph nodes, liver, and other sites, driving autoimmune responses through molecular mimicry of human autoantigens. His work has established fundamental mechanisms by which microbiota influence rheumatic diseases, cutaneous autoimmunity, and cancer immunology, with particular emphasis on Ro60 autoantigen mimicry, TLR7-dependent pathways, and diet-microbiome interactions. The laboratory employs advanced techniques including gnotobiotic mouse models, humanized systems, and detailed molecular characterization of host-pathobiont interactions. Analysis of Dr. Kriegel's publication record reveals a consistent trajectory of high-impact research connecting microbiome dynamics to autoimmune pathogenesis. His most recent work (2023-2025) demonstrates increasingly sophisticated understanding of how specific bacterial strains influence disease phenotypes across multiple autoimmune conditions, with notable advances in identifying shared microbiome signatures across lupus and inflammatory bowel disease. The publications show progressive refinement from initial observations of microbial translocation to detailed mechanistic insights into tryptophan catabolism pathways, structural basis of molecular mimicry, and diet-sensitive microbial triggers. Dr. Kriegel's scientific recognition includes US Patent No. 11,058,756 B2 for compositions treating autoimmune diseases by reducing enterococcus, reflecting the translational potential of his research. His laboratory receives substantial funding, most notably a $3 million award from the Lupus Research Alliance for the TransLuMi project investigating gut pathobiont translocation in systemic lupus erythematosus. As an educator and mentor, Dr. Kriegel directs a substantial research team including multiple postdocs (Drs. Marcia Pereira, Nathalie Becker), PhD candidates (Anna Brinkhege, Carina Brune, Helen Fuhrmann), and laboratory specialists. He participates in the CiM-IMPRS graduate program and supervises medical students through the MedK program. His laboratory currently manages multiple significant research projects including: (A) intestinal wall permeability and pathobiont translocation in autoimmunity; (B) diet-environment-microbiome interactions; (C) microbiota disruption of immunological tolerance; and (D) microbiome roles in lymphoma development. The Kriegel laboratory maintains state-of-the-art facilities at both Münster and Yale, with specialized capabilities in gnotobiotic research, microbiome analysis, and immune profiling. His team collaborates with international partners including Dr. Eran Elinav at Weizmann Institute, Dr. Nissan Yissachar at Bar-Ilan University, Prof. George Tsokos at Harvard, and Prof. Ilana Brito at Cornell University. The laboratory's website (https://www.medizin.uni-muenster.de/mikrobiom/startseite/) details ongoing projects and research opportunities.
Rainer Böckmann is a Professor of Computational Biology in the Department of Biology at Friedrich-Alexander-University Erlangen-Nürnberg (FAU), Germany, where he leads the Group for Theoretical and Computational Membrane Biophysics. His research integrates molecular dynamics simulations with biophysical analysis to study membrane structure, dynamics, and function. Research Interests: His work focuses on computational biophysics, particularly lipid bilayers, membrane proteins, molecular dynamics, and structural bioinformatics. He investigates how lipid composition, cholesterol, and embedded peptides influence membrane organization, curvature, and permeability, with applications in antimicrobial strategies and mRNA vaccine delivery systems. Recent Research Trends: His recent publications reflect a strong emphasis on lipid nanoparticles (LNPs), particularly their phase behavior, pH-dependent protonation, and structural transitions relevant to mRNA vaccines. He also explores antimicrobial peptides, membrane domain formation, and the role of cholesterol in modulating membrane properties. His group develops and applies advanced simulation techniques, including constant-pH MD and coarse-grained modeling. Member of Editorial Board, Biophysical Journal (2024–present) Elected Member, DFG Review Board for Biophysics (2020–present) Chairman, Molecular Biophysics Section, German Biophysical Society (2011–2012) Leadership and Service: Böckmann is actively involved in academic governance, serving on editorial boards, DFG committees, and as a guest editor for special issues in Frontiers journals. He contributes to graduate education and high-performance computing initiatives at FAU, including the NHR@FAU and Life@FAU Graduate School. He has organized major conferences and workshops in biophysics and membrane modeling. Laboratory and Collaboration: He leads a research group focused on biomembrane physics, collaborating with experimentalists and theorists. His lab develops and applies simulation tools to study membrane systems, bridging computational insights with biological function.
